Download presentation
Presentation is loading. Please wait.
1
Volume 61, Issue 4, Pages 1469-1474 (April 2002)
A placebo-controlled trial examining atorvastatin in dyslipidemic patients undergoing CAPD Kevin P.G. Harris, David C. Wheeler, Camilla C. Chong, the Atorvastatin in CAPD Study Investigators Kidney International Volume 61, Issue 4, Pages (April 2002) DOI: /j x Copyright © 2002 International Society of Nephrology Terms and Conditions
2
Figure 1 Summary of percent change from baseline for lipid parameters for atorvastatin (▪;N = 79) versus placebo (□;N = 89) at 16 weeks. Kidney International , DOI: ( /j x) Copyright © 2002 International Society of Nephrology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.